P2Y12 inhibitors: all 610 studies that test it

Page 6 of 7. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.

• Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and PlasmaStatus unknownNCT01264640Not applicable
• Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent ImplantationStatus unknownNCT01233167Not applicable
• Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.CompletedNCT01226602Phase 1
• Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral TramadolCompletedNCT01214941Phase 4
• An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of ClopidogrelCompletedNCT01210339Phase 1
• Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)CompletedNCT01186146Phase 4
• Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.CompletedNCT01175200Not applicable
• Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass GraftingCompletedNCT01159639Phase 4
• Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMIStatus unknownNCT01158846Phase 4
• Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of ClopidogrelCompletedNCT01147588Phase 1
• Comparison of Generic and Original Formulation of ClopidogrelCompletedNCT01147133Phase 4
• Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac SurgeryCompletedNCT01146301Phase 4
• Anticoagulation in Stent InterventionStatus unknownNCT01141153Phase 4
• Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCICompletedNCT01135667Phase 4
• Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy SubjectsCompletedNCT01129427Phase 1
• Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCompletedNCT01129414Phase 1
• Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy SubjectsCompletedNCT01129388Phase 1
• Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCompletedNCT01129375Phase 1
• Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy SubjectsCompletedNCT01129271Phase 1
• Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy SubjectsCompletedNCT01129063Phase 1
• Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy SubjectsCompletedNCT01123824Phase 1
• Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize TrialCompletedNCT01113372Phase 4
• Effects of Clopidogrel on Blood PressureCompletedNCT01112137Phase 4
• Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)CompletedNCT01108588Phase 1
• Plavix, Prasugrel and Drug Eluting Stents Pilot TrialStatus unknownNCT01103843Not applicable
• Clopidogrel/Aspirin Interaction StudyCompletedNCT01102439Phase 4
• Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent ImplantationCompletedNCT01094457Phase 4
• Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in JapanCompletedNCT01069302Phase 4
• ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft SurgeryStatus unknownNCT01046942Phase 3
• The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel ResistanceCompletedNCT01032668Phase 3
• Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ AssayStatus unknownNCT01023360Phase 4
• Platelet Reactivity in Stent Thrombosis PatientsCompletedNCT01012544Phase 4
• Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.WithdrawnNCT01011257Phase 4
• Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular EventsCompletedNCT00979589Phase 3
• Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD EquivalentsCompletedNCT00947843Phase 4
• Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet TherapyTerminatedNCT00944333Phase 3
• Clopidogrel and Aspirin for the Treatment of Polycythemia VeraWithdrawnNCT00940784Phase 2
• Ex Vivo Human Thrombosis Chamber StudyCompletedNCT00935506Phase 1
• Tailoring Of Platelet Inhibition to Avoid Stent ThrombosisCompletedNCT00914368Phase 2
• Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) PolymorphismStatus unknownNCT00891670Phase 3
• Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial InfarctionCompletedNCT00882739Phase 4
• The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal VolunteersCompletedNCT00882388Phase 4
• Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial DiseaseCompletedNCT00862420Phase 3
• Resistance to Antithrombotic TherapyCompletedNCT00858715Not applicable
• Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary AngioplastyCompletedNCT00827346Phase 2/3
• Clopidogrel and Response Variability Investigation Study 2CompletedNCT00822666Phase 3
• Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent ImplantationCompletedNCT00822536Phase 4
• Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being PlannedCompletedNCT00821834Phase 3
• COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic StrokeCompletedNCT00814268Phase 4
• Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal DefectsCompletedNCT00799045Phase 4
• Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)CompletedNCT00781573Not applicable
• Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal UlcersCompletedNCT00778193Phase 4
• Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent ImplantationStatus unknownNCT00776633Phase 4
• The Clopidogrel and Aspirin After Surgery for Coronary Artery DiseaseStatus unknownNCT00776477Phase 3
• Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular EventsStatus unknownNCT00775762Phase 3
• Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)Status unknownNCT00751491Phase 3
• Uric Acid Study in Healthy Male VolunteersCompletedNCT00738842Phase 1
• Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy VolunteersCompletedNCT00733265Phase 1
• Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)CompletedNCT00728156Phase 4
• Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.CompletedNCT00724880Phase 4
• An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy VolunteersCompletedNCT00721448Phase 1
• CASTLE (Clopidogrel And Serum Troponin Level Elevation)CompletedNCT00716924Phase 3
• Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial InfarctionCompletedNCT00714961Phase 3
• Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy VolunteersCompletedNCT00699504Phase 1
• Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTingCompletedNCT00698607Phase 4
• Healthy Volunteer Study of Clopidogrel and RifampicinCompletedNCT00696566Phase 1
• Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet FunctionCompletedNCT00693069Phase 3
• AZD6140 Oral Contraceptive Interaction StudyCompletedNCT00685906Phase 1
• Anticoagulant Treatments and Percutaneous Coronary AngioplastyTerminatedNCT00669149Phase 4
• Standard Medical Management in Secondary Prevention of Ischemic Stroke in ChinaCompletedNCT00664846Not applicable
• Warfarin After Anterior ST-Elevation Myocardial InfarctionCompletedNCT00662467Not applicable
• Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting StentingStatus unknownNCT00661206Phase 4
• Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00650169Phase 1
• Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00648947Phase 1
• Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial FunctionCompletedNCT00648453Phase 4
• GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And SafetyCompletedNCT00645918Not applicable
• Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES ImplantationTerminatedNCT00640679Phase 4
• Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet ReactivityTerminatedNCT00638326Phase 3
• The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of CilostazolCompletedNCT00620646Not applicable
• Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary StentsWithdrawnNCT00589862Phase 4
• Platelet Function Assessment for Atherothrombotic PatientsStatus unknownNCT00513149Phase 4
• Association of Clopidogrel Therapy and Stent ThrombosisCompletedNCT00484926Phase 4
• Clopidogrel Reloading in Clopidogrel Resistant Patients With ACSCompletedNCT00444132Phase 3
• H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to ClopidogrelCompletedNCT00433784Phase 4
• Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?CompletedNCT00432120Phase 3
• Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.TerminatedNCT00421252Phase 4
• The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor StentCompletedNCT00418860Not applicable
• Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy SubjectsCompletedNCT00413608Phase 1
• Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent ImplantationCompletedNCT00404053Phase 4
• Safety and Efficacy of Clopidogrel for Cerebral Infarction TreatmentCompletedNCT00386191Phase 4
• CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial InfarctionCompletedNCT00372216Phase 3
• ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"CompletedNCT00360386Phase 2
• Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein TrialCompletedNCT00343876Phase 4
• Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG StudyCompletedNCT00330772Phase 3
• Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment ElevationCompletedNCT00325390Phase 3
• PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic SyndromeCompletedNCT00296803Phase 4
• Optimum Platelet Inhibition After Coronary Bypass SurgeryCompletedNCT00262275Not applicable
• Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)TerminatedNCT00243178Phase 3
• Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial InfarctionCompletedNCT00222573Phase 4
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.CompletedNCT00222261Phase 4

← P2Y12 inhibitors overview